Trials / Unknown
UnknownNCT00749697
Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
Investigating Absorbed Radiation Dose Delivered to Differentiated Thyroid Cancer Metastases Following Administration of Fixed Activity of Radioactive Iodine
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of the study is to establish a relationship between the administered activity of the radioiodine and absorbed dose in the tumor sites.
Detailed description
Study Design - the assessment of patients with multiple tumour sites with metastatic thyroid cancer to correlate the administered activity to absorbed dose. Patients will receive the standard therapy dose of 5.5 GBq as per the hospital policy and there will be no change for the protocol purpose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SPECT scan | SPECT scan measures the amount of radio activity that is remaining in patients' body after the consumption of radio iodine for therapeutic purpose |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2010-01-01
- Completion
- 2010-07-01
- First posted
- 2008-09-09
- Last updated
- 2008-09-09
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00749697. Inclusion in this directory is not an endorsement.